ArticleRisk management and healthcare policy2026
Demographic and Geographic Heterogeneity in Tongue Cancer Mortality in the United States, 1999-2020.
Article in Risk management and healthcare policy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Tongue cancer remains a significant public health concern due to its persistently high mortality. However, population-level evidence on long-term trends and geographic inequities, particularly urban-rural disparities, remains limited. This observational ecological study examined national temporal trends and demographic and geographic heterogeneity in tongue cancer mortality. Methods: We analyzed mortality data from 1999-2020 obtained from the Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research (CDC WONDER). Deaths were identified using ICD-10 codes C01-C02 as the underlying cause. Age-adjusted mortality rates (AAMRs) and estimated annual percent change (EAPC) were used to quantify trends. Analyses were stratified by sex, race or ethnicity, age group, US Census region, urbanization level, and state. Frontier analysis assessed the association between state-level mortality rates and the socio-demographic index (SDI). Results: A total of 47,943 tongue cancer deaths were recorded, with an overall AAMR of 0.660 per 100,000 population. Mortality increased modestly from 0.617 to 0.683 per 100,000 (EAPC, 0.262%). Urban-rural disparities were pronounced: urban rates remained stable (EAPC, 0.039%), whereas rural rates increased significantly (EAPC, 1.103%), reversing from lower than urban in 1999 to higher by 2020 (0.742 vs 0.662). Men experienced approximately threefold higher mortality than women, with increases confined to men. Mortality rose among White individuals but declined among Black individuals, and deaths were concentrated in older adults. Regionally, mortality increased in the Midwest and declined in the Northeast. Frontier analysis demonstrated an inverse association between SDI and AAMR. Conclusion: Tongue cancer mortality in the US has remained relatively stable overall but exhibits widening rural disadvantages, persistent male predominance, divergent racial trends, regional heterogeneity, and a concentration among older adults. These findings underscore the need for equity-focused, geography-based interventions, particularly in rural communities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.